Director/PDMR Shareholding
Kosmos Energy Ltd (the "Company")
PDMR ShareholdingNOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
1 June 2026
The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:
PDMR
Date of transaction
No. of shares vested
No. of shares granted
No. of shares sold or withheld
Roy A. Franklin
27 May 2026
0
0
976
Roy A. Franklin
28 May 2026
0
0
43,466
Roy A. Franklin
28 May 2026
0
62,044
0
Deanna L. Goodwin
28 May 2026
0
62,044
0
Sir John Douglas Kelso Grant
27 May 2026
0
0
735
Sir John Douglas Kelso Grant
27 May 2026
0
0
43,466
Sir John Douglas Kelso Grant
28 May 2026
0
62,044
0
Maria Moraeus Hanssen
28 May 2026
0
62,044
0
Adebayo O. Ogunlesi
28 May 2026
0
62,044
0
Steven M. Sterin
27 May 2026
0
0
38,636
Steven M. Sterin
28 May 2026
0
62,044
0
J. Michael Stice
28 May 2026
0
62,044
0
The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
Josh R. Marion
Senior Vice President, General Counsel and Corporate Secretary
CONTACT:Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Roy A. Franklin
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
976 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
2.85
Volume
976
Total
2,781.60
e)
Aggregated information
Price
2.85
Volume
976
Total
2,781.60
f)
Date of the transactions
27 May 2026
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
43,466 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
2.73
Volume
43,466
Total
118,662.18
e)
Aggregated information
Price
2.73
Volume
43,466
Total
118,662.18
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Deanna L. Goodwin
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Sir John Douglas Kelso Grant
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
735 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
2.85
Volume
735
Total
2,094.75
e)
Aggregated information
Price
2.85
Volume
735
Total
2,094.75
f)
Date of the transactions
27 May 2026
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
43,466 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
2.73
Volume
43,466
Total
118,615.59
e)
Aggregated information
Price
2.73
Volume
43,466
Total
118,615.59
f)
Date of the transactions
27 May 2026
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Maria Moraeus Hanssen
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Adebayo O. Ogunlesi
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Steven M. Sterin
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
38,636 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
2.73
Volume
38,636
Total
105,476.28
e)
Aggregated information
Price
2.73
Volume
38,636
Total
105,476.28
f)
Date of the transactions
27 May 2026
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
J. Michael Stice
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
2.74
Volume
62,044
Total
170,000
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
2.74
Volume
62,044
Total
170,000
f)
Date of the transactions
28 May 2026
g)
Place of the transaction
NYSE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHSSMFFFEMSEIM
